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ABSTRACT 
Attention-Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder 
characterized by symptoms of inattention and/or a combination of hyperactivity and 
impulsivity.  Motor problems, including poor graphomotor skills, are frequently found in 
those with ADHD and have been noted to be undertreated.  Variability of performance 
within several domains has also been indicated as a hallmark of ADHD.  The present 
study sought to 1) determine whether the variability of performance observed in other 
psychological domains in those diagnosed with ADHD manifests within kinematic 
variables of graphomotor output and 2) determine whether a novel writing task 
differentially affects the graphomotor output of adults diagnosed with ADHD versus 
controls.  Findings and implications are discussed. 
 Keywords: digitizing tablet, stimulant medication, fine motor skills, 
variability of task performance 
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CHAPTER I 
INTRODUCTION 
Attention-Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental 
disorder characterized primarily by symptoms of inattention and/or a combination of 
hyperactivity and impulsivity (Barkley, 2006).  In addition to the diagnostic criteria that 
define ADHD, several other impairments have been consistently identified in those with 
ADHD.  These characteristics include motor skill impairments, such as poor handwriting, 
and variability of task performance, which manifests within several domains.  One 
promising method that has been used to investigate graphomotor functioning (i.e., 
handwriting) is kinematic analysis, which has historically involved the use of digitizing 
technology.  Kinematic analysis of graphomotor functioning in the ADHD population has 
indicated that within the context of medication status (i.e., whether taking prescribed 
dosages of stimulant medication or having discontinued medication), children with 
ADHD differ in automatized graphomotor fluency when compared to unaffected 
children.  Similar results have not been documented in adults with ADHD.  However, no 
study has investigated whether the variability of performance that is observed within the 
ADHD population extends into the graphomotor domain. 
 2 
CHAPTER II 
REVIEW OF LITERATURE 
Diagnostic Criteria 
The most recent version of the Diagnostic and Statistical Manual of Mental 
Disorders (DSM-IV-TR; American Psychiatric Association, 2000) estimates the 
prevalence of ADHD to be between 3% and 7% of school aged children in the United 
States.  In adults, the prevalence of ADHD has been estimated at approximately 4% (as 
cited in Biederman, 2005).  Data demonstrating persistence of ADHD symptomatology 
from childhood into adulthood are mixed, with estimates ranging between 4% 
(Mannuzza, Klein, Bessler, Malloy, & LaPadula, 1998) and 85% (Barkley, Fischer, 
Smallish, & Fletcher, 2002).  Although estimations may be conservative in general (Root 
& Resnick, 2003), Barkley (2006) has indicated that prevalence estimates of ADHD 
differs based on a variety of factors, including sex, age, diagnostic criteria, data collection 
methods, and country of origin. 
Utilizing criteria described in the DSM-IV-TR, a diagnosis of ADHD can be 
given to those who demonstrate either “six (or more)” symptoms of inattention and/or 
“six (or more)” symptoms related to hyperactivity and impulsivity that “have persisted 
for at least 6 months to a degree that is maladaptive and inconsistent with developmental 
level” (American Psychiatric Association, 2000, p. 92).  Further, these symptoms must 
have been observed before the individual was 7 years old and with impairment occurring 
in two or more settings (e.g., at school, in the home, and/or in the work-place).  Specific 
subtypes of ADHD, which correspond to different combinations of symptomatology, 
include ADHD combined type (ADHD-C), ADHD Predominantly Inattentive Type 
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(ADHD-PI), and ADHD Predominantly Hyperactive-Impulsive Type (ADHD-HI).  A 
diagnosis of ADHD-C requires that both six or more symptoms of inattention and six or 
more symptoms of hyperactivity-impulsivity have been present for at least the past six 
months.  The ADHD-PI subtype is indicated when six or more symptoms of inattention 
are present for at least six months, but fewer than six symptoms of hyperactivity-
impulsivity are present during this same time period.  Finally, a diagnosis of ADHD-HI is 
appropriate if six or more symptoms related to hyperactivity-impulsivity have been 
present for at least the past six months, but fewer than six symptoms of inattention are 
present during this same time period. 
Etiology of ADHD 
The etiology of ADHD is complex in nature, although recent research implicates 
neurological and genetic factors as primary agents of pathogenesis (Barkley, 2006).  The 
advent and subsequent popularity of modern neuroimaging techniques such as magnetic 
resonance imaging (MRI) and diffusion tensor imaging (DTI) have enhanced the ability 
of researchers to analyze the structural neuroanatomy of individuals in a non-invasive 
manner.  In the case of ADHD, several consistent findings have emerged with regard to 
abnormal structure of the central nervous system (Barkley, 2006).  Widespread 
reductions of cortical gray matter have been found in the frontal, parietal, temporal, and 
occipital lobes of the cerebral cortex in general (Batty et al., 2010; Shaw et al., 2006) and 
in frontal and posterior association cortices in particular (Narr et al., 2009).  Although 
findings vary to some degree between studies, reductions in gray matter volume have 
been found in more circumscribed areas of the cortex and subcortical nuclei in both 
children and adults with ADHD.  These areas include the prefrontal and dorsolateral 
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prefrontal cortices, basal ganglia (caudate nucleus, globus pallidus, putamen, and 
substantia nigra), and anterior cingulate cortex (Amico, Stauber, Koutsouleris, & Frodl, 
2010; Castellanos, Geidd, Marsh, & Hamburger, 1996; McAlonan et al., 2007; Romanos 
et al., 2010; Seidman et al., 2011).  Reductions in the infratentorial structural volume of 
the cerebellar vermis have also been found in both children (Castellanos et al., 2001; 
Durston et al., 2004; Mackie et al., 2007) and adults (Seidman et al., 2011) diagnosed 
with ADHD.   
Research also indicates that although those diagnosed with ADHD do not 
consistently demonstrate global reductions in white matter volume compared to controls 
(Amico et al., 2010; Batty et al., 2010; Durston et al., 2004; McAlonan et al., 2007; Narr 
et al., 2009), reduced white matter volumes in specific areas of the cerebrum have been 
more consistently documented.  For example, McAlonan et al. (2007) found that white 
matter tracts of the corpus callosum evidenced reduced volume in those diagnosed with 
ADHD.  This finding is consistent with past studies indicating reduction in white matter 
of the corpus callosum in general (Hynd et al., 1991) and the splenium of the corpus 
callosum in particular (Semrud-Clikeman et al., 1994).  Other studies investigating the 
structural integrity of white matter pathways connecting different regions of the cerebrum 
suggest that these pathways appear to be compromised in the ADHD population (Konrad 
& Eickhoff, 2010).  More specifically, the superior longitudinal fasciculus and anterior 
corona radiata, which are tracts projecting between the frontal cortex and basal ganglia, 
have evinced reduced white matter integrity in children and adults based on 
measurements of fractional anisotropy (FA; representing the directionality and shape of 
the water molecules within the tract), mean diffusivity (MD), and apparent diffusion 
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coefficient (ADC; representing the volume of white matter diffusion) (Liston, Cohen, 
Teslovich, Levenson, & Casey, 2011).  Due to the aforementioned inconsistencies in 
white matter volumetric findings in the ADHD literature, however, firm conclusions 
concerning the role of white matter pathways in the pathophysiology of ADHD cannot be 
drawn at this time. 
Although relationships between ADHD symptomatology and structural 
abnormalities can only be inferred due to the nature of these studies, functional 
neuroimaging techniques, such as functional magnetic resonance imaging (fMRI), 
provide additional evidence that structures believed to subserve abilities related to 
attention, inhibition, and motor control – abilities that are impaired in those with ADHD 
– are the same structures that demonstrate structural abnormalities in ADHD (Brossard-
Racine, Majnemer, & Shevell, 2011; Seidman et al., 2006; Swanson, Castellanos, Murias, 
LaHoste, & Kennedy, 1998; Shaw et al., 2006).  Compared with healthy children, 
children with ADHD show abnormal patterns of activation (i.e., hypo-activation) in the 
prefrontal cortex, basal ganglia, and cerebellum when performing tasks related to 
attention, inhibition, motor control, and executive function (Bush et al., 1999; Durston et 
al., 2003; Posner et al., 2011; Rubia et al., 1999; Teicher et al., 2000; Vaidya et al., 1998; 
Yeo et al., 2003).  Differences also appear to persist into adulthood.  For example, 
Cubillo, Halari, Giampietro, Taylor, & Rubia (2011) found that compared with 
neurotypical individuals, medication naive adults diagnosed with ADHD in childhood 
who continued to demonstrate symptomatology into adulthood were found to have 
reduced activation in the orbital frontal cortex, medial frontal cortex, and striatum (i.e., 
basal ganglia) during tasks requiring inhibition, as well as reduced activation in the lateral 
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inferior and dorsolateral prefrontal cortices during tasks of working memory and 
attention. 
Although studies have not demonstrated that ADHD occurs as a result of 
chromosomal abnormalities, several lines of research (i.e., family, adoption, twin, and 
genetic studies) indicate that ADHD has a high degree of heritability (Barkley, 2006).  
Highlighting the heritable and familial nature of ADHD – with some heritability rates 
estimated to be as high 0.76 (Faraone et al., 2005) – are findings that asymptomatic 
siblings of those diagnosed with ADHD demonstrate a trend towards similar volumetric 
reductions in cortical regions comparable with those found in their affected siblings 
(Durston et al., 2004).   
At least seven genes appear to be implicated in the etiology of ADHD (Faraone et 
al., 2005), although several other genes are currently under investigation (see 
Banaschewski, Becker, Scherag, Franke, & Coghill, 2010, for a review).  One example is 
the dopamine transporter gene, DAT1, which has received significant attention as 
mutations of this gene have been found to be related to presence of ADHD 
symptomatology in both adults (Brown et al., 2011) and children (Daly, Hawi, Fitzgerald, 
& Gill, 1999). 
Dysfunction or imbalance of dopamine (DA), norepinephrine (NE), and 
noradrenaline (NA) neurotransmitters have also been implicated in the pathophysiology 
of ADHD (Arnsten, Berridge, & McCracken, 2009; Barkley, 2006; Biderman, 2005).  In 
a recent review of the literature investigating the influences of DA and NA in ADHD, del 
Campo, Chamberlain, Sahakian, and Robbins (2011) suggested that DA and NA may 
play more specific roles in the presentation of ADHD symptomatology.  That is, whereas 
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a combination of DA and NA abnormalities may affect functioning of the prefrontal 
cortex and by extension abilities related to inhibition, DA alone may affect functioning of 
subcortical structures such as the basal ganglia, in turn affecting attentional abilities. 
Impairments Associated with ADHD 
Beyond the primary symptoms of inattention, hyperactivity, and impulsivity, 
decades of research has demonstrated that ADHD is associated with numerous 
impairments affecting various domains of activities and functioning.  Areas of 
impairment include cognitive functioning, language development and expression, motor 
skills, emotional regulation, academic performance, consistency of task performance, and 
general health and well-being (Barkley, 2006).  Of particular interest here are the motor 
control problems, which are often under-treated in this population (Fliers et al., 2009), 
and the variability of task performance and expression. 
Individuals diagnosed with ADHD have been shown to demonstrate variability in 
task performance and behaviours within several domains, including emotional expression 
(i.e., emotional lability; Barkley & Fischer, 2010; Posner et al., 2011), qualitative and 
quantitative handwriting production (Rosenblum, Epsztein, & Josman, 2008), in-phase 
bimanual coordination (Klimkeit, Sheppard, Lee, & Bradshaw, 2004), motor force output 
(Pereira, Eliasson, & Forssberg, 2000), and fine motor skill movements (Pitcher, Piek, & 
Barrett, 2002).  Anecdotal reports from teachers and parents also suggest that children 
diagnosed with ADHD, as compared to healthy children, display a great deal of 
variability in their academic work and the quality with which they complete household 
duties (Barkley, 2006).  Due to the observation that variability of task performance has 
been documented in several domains and appears to be ubiquitous in this population, 
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“some believe [variability of task performance] to be a primary deficit in ADHD” 
(Barkley, 2006, p. 136). 
Although it is still unclear whether or not developmental motor milestones are 
generally delayed in children with ADHD (Barkley, 2006), the pervasive nature of motor 
difficulties that are observed in this population is highlighted by findings demonstrating 
significant comorbidity with Developmental Coordination Disorder, which is 
characterized by “marked impairment in the development of motor coordination” that 
“significantly interferes with academic achievement or activities of daily living” 
(American Psychiatric Association, 2000, pp. 56-57), when compared to the general 
population (Kadesjo & Gillberg, 2001; Piek, Pitcher, & Hay, 1999).  Indeed, there is 
some evidence to suggest that ADHD and Developmental Coordination Disorder (DCD) 
share a genetic component (Martin, Piek, & Hay, 2006).  Regardless of the presence of 
DCD, it is clear that those diagnosed with ADHD demonstrate motor impairments more 
frequently than the general population (Brossard-Racine, Majnemer, & Shevell., 2011).  
Examples of motor impairments found in those diagnosed with ADHD include poor 
handwriting (Brossard-Racine, Majnemer, Shevell, Snider, & Belanger, 2011); decreased 
speed and accuracy of complex (but not simple) fine and tactual motor performance 
(Meyer & Sagvolden, 2006); and deficits in balance, manual dexterity, coordination, and 
fine and gross motor skills (Piek, Pitcher, & Hay, 1999).  Highlighting the importance of 
impairments in both motor functioning in general and timing of motor behaviour in 
particular are studies indicating that these problems are not only found in those diagnosed 
with ADHD, but also in siblings without an ADHD diagnosis.  For example, Rommelse 
and colleagues (2008) found this relationship between affected and non-ADHD siblings 
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and concluded that based on the evidence, “Variability in motor timing appears a useful 
endophenotypic candidate: It is clearly associated with ADHD, it is also present in non-
ADHD siblings, and it correlates within families” (p. 131).  “Moderate” and statistically 
significant positive correlations between severity of ADHD symptomatology and severity 
of motor sequelae have also been documented (Rommelse et al., 2009), which provide 
additional support for the notion that both motor control dysfunction and variability in 
task performance could be considered as primary deficits in those diagnosed with ADHD.   
Relevant to the academic success of children is the skill of handwriting.  In a 
review of the literature investigating the handwriting skills of children diagnosed with 
ADHD, Brossard-Racine, Majnemer, Shevell, and Snider (2008) concluded that the 
handwriting of individuals in this population can be characterized as impaired, often 
illegible, and less organized than the handwriting of control children, which in turn 
results in low academic achievement.  Poor qualitative writing observed in this 
population does not appear to be related to pure visual-perceptual, visual-motor 
integration, or linguistic difficulties; instead, poor performance likely involves many 
different processes (Brossard-Racine et al., 2008), including dysfunction in basic 
parameter setting, such as regulation of force, speed, and size of graphomotor movements 
(van Galen, 1991); motor control; and timing aspects of handwriting (Adi-Japha et al., 
2007; Marcotte & Stern, 1997; Schoemaker, Ketelaars, van Zonneveld, Minderaa, & 
Mulder, 2005). 
Kinematic Analysis of Handwriting 
The volitional control of handwriting can be thought of as a complex process 
involving the integration of “cognitive, psychomotor, and biophysical processes” (van 
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Galen, 1991, p. 165) that are organized hierarchically and in parallel (Plamondon, 1995a) 
to produce meaningful visual-spatial output.  Using a motor program metaphor, 
graphomotor processes begin with the retrieval of a high-level representation of the 
desired motor output - which might involve acquiring trajectory based stroke segments 
that can be combined to form complex symbols as opposed to retrieving whole letters or 
words stored within a visual-spatial “brain dictionary” (Lacquaniti, 1989, p. 287).  This in 
turn is followed by a conversion of this representation into motor control “commands,” 
finally ending with the neuromuscular system responding in the desired manner 
(Plamondon, Yu, Stelmach, & Clement, 1991).  In addition, the neuromuscular and 
higher-order systems make necessary adjustments based on relevant “visual and/or 
kinesthetic feedback” (Dooijes, 1983, p. 104).  Central nervous system structures likely 
involved in these motor output processes include the primary motor cortex, premotor 
cortex, supplemental motor area, basal ganglia, cerebellum, and spinal cord (Plamondon, 
1995a).   
Studies investigating the cognitive, psychomotor, and biophysical processes 
involved in graphomotor control generally support this process and its related 
components (Meulenbroek & Thomassen, 1993; Meulenbroek & van Galen, 1988; 
Portier & van Galen, 1992; Teulings, Thomassen, & van Galen, 1983; van Galen, 1990; 
Woch, Plamondon, & O’Reilly, 2011; see Plamondon & Maarse, 1989, for a review and 
evaluation of computational motor models of handwriting), with the initial phases of 
voluntary motor control represented by measurements of reaction time and the latter 
phases represented by measurements of total movement time (Bellgrove et al., 1997) and 
other variables.  The use of objective tools and methods to assess handwriting movements 
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(e.g., kinematic analysis), then, can be viewed as a method to make inferences about 
these cognitive, psychomotor, and biophysical processes underlying graphomotor 
function.   
Kinematic analysis involves the quantification of “time changes of position, 
velocity, and acceleration” (Viviani & Terzuolo, 1982, p. 431).  Although many 
technological options are available for kinematic analysis, the use of digitizing tablets to 
capture handwriting signals has predominated in graphonomic research of both healthy 
and clinical populations over the past 30 years (for a review of early graphomotor 
research, including the use of digitizing tablets, see Graham & Weintraub, 1996).  In the 
domain of graphonomics, kinematic measures can be quantified using parameters of time, 
acceleration, velocity, and pen pressure, and variables derived from these basic measures 
can be used to (a) describe abilities related to degree of movement automatization and 
fluency (Eichhorn et al., 1996; Margolin & Wing, 1983; Mergl, Tigges, Schroter, Moller, 
& Hegerl, 1999; Portier & van Galen, 1992; Teulings, Contreras-Vidal, Stelmach, & 
Adler, 1997; Yan, Rountree, Massman, Doody, & Li, 2008); (b) quantify the relative 
decelerations and accelerations of handwriting movements (Eichhorn et al., 1996; Mergl 
et al., 1999; Plamondon & Clement, 1991; van Galen, Portier, Smits-Engelsman, & 
Schomaker, 1993); (c) indicate stability, coordination, and consistency of an individual’s 
handwriting (Mergl et al., 1999; Schroter et al., 2003; Teulings & Schomaker, 1993; 
Slavin, Phillips, Bradshaw, Hall, & Presnell, 1999); (d) indicate the sharing of processing 
resources, the difficulty of writing trajectories, and the presence of dysmetria (van Galen, 
1991; Teulings, Contreras-Vidal, Stelmach, & Adler, 1997; Phillips et al., 2009); (e) 
quantify fine motor hypotonia and general proficiency (Mergl et al., 1999; Wann & 
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Nimmo-Smith, 1991; Phillips et al., 1999); and (f) indicate the smoothness and efficiency 
of movements (Bellgrove et al., 1997; Phillips et al., 2009).  In this sense, the metrics 
produced by kinematic analyses of handwriting can be viewed as objective rather than 
subjective measurements of graphomotor performance. 
Clinical Research Utilizing Kinematic Analysis 
The use of digitizing technology to quantify graphomotor processes as an 
investigative and potentially diagnostic tool has been conducted with a multitude of 
patient populations.  Pathologies and disorders investigated include, but are not limited 
to, ADHD (e.g., Adi-Japha et al., 2007; Flapper, Houwen, & Schoemaker, 2006; 
Schoemaker et al., 2005; Tucha & Lange, 2001, 2004, 2005; Tucha, Paul, & Lange, 
2003);  Dementia, Alzheimer’s Disease, and Mild Cognitive Impairment (e.g., Bellgrove 
et al., 1997; Yan et al., 2008); DCD (e.g., Bo, Bastien, Kagerer, Contreras-Vidal, & 
Clark, 2008; Chang & Yu, 2010; Rosenblum & Livneh-Zirinski, 2008; Smits-Engelsman 
Niemeijer, & van Galen, 2001); Dysgraphia (e.g., Kushki, Schwellnus, Ilyas, & Chau, 
2011; Overvelde & Hulstijn, in press; Rosenblum, Dvorkin, & Weiss, 2006; Smits-
Engelsman & van Galen, 1997); Huntington’s Disease (e.g., Phillips et al., 1996; Phillips, 
Chiu, Bradshaw, & Iansek, 1995; Slavin et al., 1999; Yaguez, Canavan, Lange, & 
Homberg, 1999); Learning Disability (e.g., Galli et al., 2011; van Roon, Caeyenberghs, 
Swinnen, & Smits-Engelsman, 2010); Schizophrenia (e.g., Grootens et al., 2009; Jahn et 
al., 2006; Putzhammer et al., 2005; Tigges et al., 2000); and Parkinson’s Disease (e.g., 
Gangadhar et al., 2009; Poluha, Teulings, & Brookshire, 1998; Ponsen et al., 2006; Rand, 
Stelmach, & Bloedel, 2000; van Gemmert, Teulings, & Stelmach, 1998).  Germane to the 
present study are findings related to ADHD.   
13 
 
13 
Using qualitative variables such as legibility; spacing, letter size, and alignment 
consistency; organization of material within space; and letter insertions, transpositions, 
substitutions, and omissions, studies of handwriting produced by children diagnosed with 
ADHD indicate that their writing quality is generally poor, immature, and error-prone 
when compared with non-ADHD controls (Adi-Japha et al., 2007; Flapper et al., 2006; 
Lerer, Artner, & Lerer, 1979; Marcotte & Stern, 1997; Whalen, Henker, & Finck, 1981; 
Tucha & Lange, 2001).  In addition, poor qualitative performance does not appear to be 
the result of purely linguistic, visual, perceptual, or visual motor integration deficits (Adi-
Japha et al., 2007; Marcotte & Stern, 1997) and typically improves after taking prescribed 
dosages of stimulant medication (Lerer et al., 1979; Tucha & Lange, 2001; Whalen et al., 
1981).  Interestingly, kinematic analyses assessing objective, process related aspects of 
handwriting indicate that the handwriting produced by children diagnosed with ADHD is 
more dysfluent and thus appears less automatized when taking stimulant medication 
compared to when they are not taking prescribed medication, and is more dysfluent when 
such children are on stimulant medication than observed in controls (Flapper et al., 2006; 
Tucha & Lange, 2001, 2004, 2005).  This pattern of fluency and dysfluency related to 
medication status, however, has not been observed in adults diagnosed with ADHD under 
similar conditions (Tucha & Lange, 2004).  In these contexts, writing fluency is 
operationalized as the number of changes in direction of velocity or acceleration as 
recorded by digitizing technology and analyzed by appropriate software.  Velocity 
profiles of fluent, automatized handwriting appear as smooth asymmetrical bell-shaped 
curves with few changes in velocity/acceleration direction, whereas dysfluent, 
unautomatized handwriting evinces velocity profiles with multiple “jagged peaks” and 
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many changes in the direction of velocity/acceleration.  See Figures 1 and 2 for examples 
of fluent versus dysfluent vertical velocity profiles, respectively. 
 
Figure 1.  Velocity profile of the word “hello” written fluently. 
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Figure 2.  Velocity profile of the word “hello” written with simulated dysfluency. 
In addition, these studies demonstrated that while off prescribed dosages of stimulant 
medication, kinematic measures of graphomotor fluency in affected children were not 
significantly different from those of non-ADHD controls.  Further, it does not appear that 
these findings are due to a direct effect of medication, as fluent movements can be 
elicited from children with ADHD taking stimulant medication (Tucha & Lange, 2004).  
Rather, this decreased fluency and automaticity may be the result of a secondary effect 
resulting from enhanced attention, from greater cognitive control (Tucha & Lange, 2004; 
Tucha, Mecklinger, Walitza, & Lange, 2006; Tucha et al., 2003), or from possibly other 
cognitive, motor, or psychomotor processes influenced by stimulant medication.  
Alternatively, Lange et al. (2007) suggested that children and adults with ADHD may, in 
general, “have difficulties in skills whose acquisition starts as a [laboured] and conscious 
learning process that becomes automatic following consistent and frequent practice” (p. 
16 
 
16 
256).  Similarly, Flapper et al. (2006) noted that typically, accuracy is achieved before 
speed and fluency when learning a complex task.  In turn, children with ADHD would 
first need to engage sufficient attentional resources and motor skills for an extended 
period of time before generating handwriting that is both fluent and accurate, noting that 
both attentional abilities and motor skills are reported to improve with methylphenidate 
treatment in adults, adolescents, and children diagnosed with ADHD (Bart, Podoly, & 
Bar-Haim, 2010; Lerer et al., 1979; Shafritz, Marchione, Gore, Shaywitz, & Shaywitz, 
2004; Stray, Stray, Iverson, Ruud, & Ellersten, 2009; Tucha, Mecklinger, Laufkotter, et 
al., 2006; Tucha, Prell, et al., 2006). 
The Present Study 
There are few studies that have investigated the kinematic aspects of writing in 
adults diagnosed with ADHD, with no study specifically examining the potential 
variability of task performance within the kinematic aspects of graphomotor skills in 
adults diagnosed with ADHD, and no study comparing novel versus putatively 
automatized graphomotor processes in this population.  As such, using a digitizing tablet 
to capture kinematic aspects of handwriting, the present study seeks to determine within 
the context of medication status 1) whether the variability of performance observed in 
other psychological domains (e.g., task persistence, emotion, and attention) in those 
diagnosed with ADHD manifests within kinematic variables associated with consistency, 
stability, and coordination during the execution of an automatized graphomotor task; and 
2) assess the effects of novelty on consistency measures of graphomotor performance 
between adults with and without ADHD.  Under the premise that handwriting output is 
generated from a velocity control perspective (i.e., that the central nervous system 
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produces volitional graphomotor output by controlling the velocity of an end-effector via 
interactions between higher-order cortical and sub-cortical systems and lower-level 
agonist and antagonist neuromuscular systems [Guerfali & Plamondon, 1997; 
Plamondon, 1993, 1995a, 1995b, 1998; Plamondon, Feng, & Woch, 2003]) and noting 
variability of performance/behaviour demonstrated in other psychological domains in 
those diagnosed with ADHD, it is hypothesized that 1) greater intra-individual variability 
in kinematic velocity measures will be observed in adults diagnosed with ADHD off 
medication when compared to neurotypical adults.  Additionally, 2) although no a priori 
hypothesis is salient with regard to the effects of novelty on variability measures in those 
diagnosed with ADHD, it could be speculated that if variability of performance observed 
in adults with ADHD extends to the graphomotor domain, ADHD participants 
discontinuing medication will be differentially affected by a novel graphomotor task and 
in turn elicit greater levels of inconsistency compared to those without ADHD.  Should 
statistically and practically significant differences become evident (i.e., differences of 
medium to large effect sizes), this would be the first study utilizing kinematic analysis to 
explicitly demonstrate variability of performance within the graphomotor domain in 
adults diagnosed with ADHD.  Significant results indicating variability in kinematic 
performance would also add to the current literature indicating that ADHD is not simply 
a disorder of childhood, but rather, a disorder in which specific motor control differences 
extend into adulthood.  Further, the results of this study would support conducting future 
research into the use of digitizing technology as an objective diagnostic and descriptive 
tool within the ADHD population, which in turn may enhance the specificity and/or 
sensitivity of current assessment and diagnostic techniques. 
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CHAPTER III 
DESIGN AND METHODOLOGY 
Participants 
Power analysis (α = .05, [1 – β] = .80) indicated that using the proposed 
methodological design and statistical analysis, 52 total participants would be needed to 
detect a statistically significant difference of large effect size.  For within-group 
differences, power analysis indicated that 16 participants would be needed to detect 
differences of large effect size. 
Thirty-eight participants were recruited through three sources:  control 
participants were recruited via the University of Windsor’s Psychology Participant Pool 
(n = 31) and clinical participants were recruited through Student Disabilities Services 
(Education Development Center) at the University of Windsor and through the private 
practice of a local psychiatrist (n = 8).  One control participant, however, requested that 
their data be removed from the study, resulting in a net of 30 control participants and 38 
total participants.  To minimize confounds related to extraneous visual and motor 
disturbances, participants included only those with normal or corrected to normal vision 
and those who did not have an existing neurological condition that would negatively 
affect graphomotor performance (e.g., cerebral palsy affecting the upper extremities, 
severe tendinitis, or carpal tunnel syndrome).  In addition, clinical participants included 
only those who were currently taking prescribed dosages of stimulant medication for the 
treatment of ADHD symptoms.  Participants recruited through the University of 
Windsor’s Psychology Participant Pool received course bonus points (1 point for control 
participants based on one hour of participation time and 2 bonus points for clinical 
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participants based on two hours of participation time) for participating in the research 
study.  Participants recruited through Student Disability Services at the University of 
Windsor and the private practice of the local psychiatrist received a $10 gift card and a 
chance to win one of two $50 debit cards via entry into a draw. 
Materials and Apparatus 
Demographic information and ADHD symptomatology.  For the purposes of 
sample description, participant demographic information including age, sex, handedness, 
current medications (including type and dosage), ethnicity, official ADHD diagnosis and 
subtype (if applicable), and neurological status was collected from each participant via an 
in-person interview (see Appendix A for the interview form used).  For participants 
diagnosed with ADHD, records pertaining to official diagnoses were reviewed and 
specific diagnoses if available (e.g., ADHD-C, ADHD-PI, ADHD-HI, and any comorbid 
diagnoses) were also recorded for descriptive purposes.  In addition, all participants 
completed the Barkley Adult ADHD Rating Scale-IV (BAARS-IV; Barkley, 2011).  
Based on DSM-IV diagnostic criteria, the BAARS-IV is a self-report questionnaire 
designed to evaluate current and/or childhood ADHD symptoms in adults between the 
ages of 18 and 81 years.  According to the manual, the normative sample used to develop 
the BAARS-IV, which consisted of 1,249 adults between the ages of 18 and 96, “closely 
approximated the U.S. adult population based on the U.S. Census from the year 2000 
concerning regional distribution, sex, race/ethnic group, marital status, employment 
status, total household income, and education” (Barkley, 2011, p. 14).  After completion 
of the questionnaire, a total ADHD score, symptom count, and subscale scores for both 
current symptoms and childhood symptoms can be calculated.  (Note: the BAARS-IV 
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also contains forms allowing current and childhood symptomatology scores to be derived 
based on reports from others through the use of an alternative quick-screen.  These were 
not utilized in this study).  The BAARS-IV also produces subscale scores related to four 
recognized ADHD symptom dimensions: Inattention, Hyperactivity, Impulsivity, and 
Sluggish Cognitive Tempo (SCT).  According to the BAARS-IV manual, ADHD scores 
at or above the 93rd percentile may be interpreted as reflecting a significant abnormality 
and clinical significance in that domain.  Because clinical participants participated in the 
research both on and off of their ADHD medication, they were asked to answer the 
questionnaire regarding their current symptomatology within the context of being off of 
their medication.  Finally, if subtype identifier information was unavailable or unknown, 
a determination of subtype was made based upon the clinical participant’s self-report 
current ADHD symptoms as measured by the BAARS-IV.  That is, for clinical 
participants only, a subtype identifier of ADHD-PI was given if significant abnormality 
was reported only within the Inattention domain, a subtype identifier of ADHD-HI was 
given if significant abnormality was reported only within the Hyperactivity or 
Impulsivity domains, and a subtype identifier of ADHD-C was given if significant 
abnormality was reported within both the Inattention domain and the Hyperactivity or 
Impulsivity domains.    
Internal consistency reliability of the BAARS-IV was reported by the manual to 
be “satisfactory” for current symptom total score and for each subscale/domain score for 
both current and childhood reported symptoms.  Test-retest reliability was described as 
“reasonable” over a 2- to 3-week period.  Finally, construct validity, discriminant 
validity, and criterion validity are reported to be “satisfactory.”  Internal consistency and 
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test-retest reliability measures for the BAARS-IV, as indicated by the manual (Barkley, 
2011), are listed in Table 1. 
Table 1 
Internal Consistency & Test-Retest Reliabilities of the BAARS-IV* 
 
Internal Consistency 
Reliability 
 
Test-Retest Reliability** 
 
Current 
Symptoms 
Childhood 
Symptoms 
 Current 
Symptoms 
Childhood 
Symptoms 
ADHD Inattention .902 .940  .66 .73 
ADHD Hyperactivity .776 .912
†
  .72 .82
†
 
ADHD Impulsivity .807   .76  
Total Score .914 .947  .75 .79 
Note. * Barkley Adult ADHD Rating Scale-IV.  ** Test-retest reliability over a 2- to 
3-week period.  
†
 Represents combined dimension of hyperactivity-impulsivity. 
 
Estimate of intellectual ability.  An estimate of IQ was derived using four 
subtests of the Wechsler Adult Intelligence Scale-Fourth Edition (WAIS-IV; Wechsler, 
2008).  Based on practical considerations and the best combination of short form 
reliability and validity coefficients (.953 and .940, respectively; see Sattler & Ryan, 
2009), the four subtests used for estimating IQ were Block Design (BD), Vocabulary 
(VC), Arithmetic (AR), and Coding (CD).  IQ estimates were used for descriptive 
purposes and for identifying initial group differences between the control group and the 
clinical group. 
Kinematic analysis and digitizing tablet.  A WACOM Cintiq 21UX digitizing 
tablet was used to record the handwriting movements of participants.  The digitizing 
tablet has an active display area of 17” by 12.75” and spatial resolution of 5080 lines per 
inch.  Because this tablet provides real-time on-screen visual feedback, a special non-
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inking pen was used by participants.  MovAlyzeR software (NeuroScript, LLC; Tempe, 
AZ, USA) was utilized to quantify handwriting movements with a maximum sampling 
rate of 200 Hz and x-y coordinates were low-pass filtered at 12 Hz.  Handwriting 
movements were broken down by MovAlyzeR software into strokes using interpolated 
vertical velocity zero crossings.  In this sense, a stroke, representing a “unit” of 
handwriting, can be defined as “a segment bounded by time moments at which the 
vertical component of the velocity changes sign” (Teulings, Thomassen, & van Galen, 
1983, p. 168).   
Kinematic variables derived using MovAlyzeR software include Relative intra-
individual standard deviation of Peak Velocity (RPV) and Normalized Jerk (NJ).  The 
RPV variable is a coefficient of variation (CV) that was derived by dividing the absolute 
standard deviation of mean peak velocity of each digitized word or symbol by the 
average peak velocity of the digitized word or symbol (Mergl et al., 1999).  The word 
“hello” and the novel symbol “ ” are described below (see Figure B1 in Appendix B 
for a scaled version of the novel symbol).  The RPV variable reflects stability, 
coordination, and consistency of an individual’s handwriting, with less consistently 
controlled movements indicated by higher values and more consistently controlled 
movements reflected by lower values (Mergl et al., 1999; Schroter et al., 2003).  An RPV 
value of 0 would indicate completely identical mean peak velocity across all trials of a 
writing task. 
NJ is a measure of writing smoothness and fluency.  High NJ scores indicate 
dysfluent movement and low NJ scores indicate smoother, fluent, and more automatized 
movement (Teulings et al., 1997; Yan et al., 2008).  Said another way, as one practices 
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and in turn automatizes a graphomotor program, dysfluency decreases (Portier & van 
Galen, 1992), as will the NJ variable.  In turn, the NJ measure should indicate greater 
dysfluency when individuals write a novel symbol or grapheme on the digitizing tablet 
versus a well-practiced and automatized symbol or grapheme.  The NJ variable is similar 
to the dysfluency measure of “number of inversions of acceleration” used in much of the 
research utilizing kinematics to investigate graphomotor problems in those diagnosed 
with ADHD (for examples, see Flapper et al., 2006; Schoemaker et al., 2005; Tucha & 
Lange, 2001, 2004, 2005; Tucha et al., 2006; and Tucha et al., 2003) in that NJ “is the 
change of acceleration per time” (Teulings et al., 1997, p. 160).  NJ, however, has the 
advantage of allowing the comparison of words or symbols of varying size and 
movement durations because it is normalized (Teulings et al., 1997). 
All demographic and research data were kept confidential and secure.  
Additionally, participant demographic and research data were de-identified (i.e., coded 
with a randomly assigned participant identification number) but still attached to 
identifying information for two weeks after the data were collected, thus giving 
participants the opportunity to withdraw their data from the study.  After this time, the 
link connecting identifying personal information with demographic and research data was 
removed and only arbitrary participant identification numbers were associated with 
demographic and research data. 
Procedures 
In the following order, participants: 1) took part in an interview with the 
researcher to provide demographic and medical information, 2) answered questions 
related to ADHD symptomatology, 3) participated in an abbreviated test of general 
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intellectual ability, 4) signed their name on the digitizing tablet 10 times, 5) wrote the 
word “hello” in lower-case using cursive handwriting on the digitizing tablet 30 times 
(representing the automatized condition), and 6) wrote the novel symbol “ ” on the 
digitizing tablet 30 times (representing the novel word condition).  A sample of this word 
and symbol was visible to the participant on a card throughout the graphomotor task.  
Instructions for all tasks were given aurally, with instruction provided visually on the 
digitizing tablet throughout. 
All data from control participants was collected in one session.  Data obtained 
from clinical participants was collected on two occasions, once while the participants 
were taking prescribed dosages of ADHD medication and a second time after abstaining 
from prescribed dosages of ADHD medication for a 24 to 48 hour period (withdrawal of 
medication time-frame based on product information indicating extremely low mean drug 
plasma concentrations between 24 and 48 hours after taking stimulant medication; U.S. 
Food and Drug Administration, 2007).  The time-frame between test and retest for this 
group was approximately one week (M = 6.75, SD = 0.71).  The demographics 
questionnaire, BAARS-IV, and WAIS-IV subtests were completed while the clinical 
participants were taking prescribed dosages of ADHD medication to minimize potential 
discomfort associated with the return of ADHD symptomatology combined with a 
relatively long research process.  The Current Symptoms form of the BAARS-IV 
questionnaire was completed while clinical participants were off of their prescribed 
ADHD medication.  Experimental task administration within the context of medication 
status was counterbalanced so that half of the clinical participants completed the writing 
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tasks while taking prescribed medication on their first visit, while the other half 
completed the writing tasks while taking prescribed medication during their second visit. 
To become familiarized with using the digitizing tablet and pen, all participants 
began the writing task by signing their name on the digitizing tablet 10 times.  
Subsequently, participants began writing experimental trials.  No specific instructions 
were given related to the quality of the handwriting participants were to produce beyond 
pointing to the sample and telling the participants to “Write the word hello in cursive and 
lower case as it is written on the card.  Just write how you typically write.”  When the 
researcher was pressed further for additional instruction, participants were only told to 
“Simply write how you typically write in cursive.”  In the case of the novel symbol, 
participants were instructed as follows: “Here is another symbol for the word ‘hello.’ 
Please write the symbol as demonstrated on the card.”  If participants questioned whether 
neatness was required, the investigator stated, “Just write it how you would write any 
other word, but make it look like the symbol as demonstrated on the card.”  Because 
handwriting is variable within individuals, even when writing the same grapheme, 
participants wrote each word and symbol 30 times in order to acquire a statistically stable 
sample of handwriting.  Finally, all participants were given the ability to manipulate the 
position of the tablet to one that was comfortable for writing, as well as position the cards 
containing the word “hello” and the novel symbol wherever was best for them. 
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CHAPTER IV 
ANALYSIS OF RESULTS 
All data analyses were performed using IBM SPSS Statistics, Version 20.0.  
Unless otherwise noted, an alpha level of .05 was used to determine statistical 
significance.  In addition, interpretations of effect sizes using ω2 were based on Kirk’s 
(2003) guidelines, such that 0.010 was interpreted as a small association, 0.059 as a 
medium association, and 0.138 or larger as a large association. 
Data Analysis of Assumptions 
Prior to hypothesis testing, the data were analyzed to determine adherence to the 
assumptions of ANOVA, repeated measures ANOVA, and mixed design ANOVA.  
Cumulatively, tested assumptions included normality of distribution and homogeneity of 
variance.  The assumptions of sphericity and homogeneity of variance/covariance 
matrices by group were not analyzed due to the research design only incorporating two 
levels of repeated measures.  Assumptions were analyzed using the variables Estimated 
IQ, Current Total ADHD Score, Childhood Total ADHD Score, NJ under the 
automatized writing task condition, and RPV under both the automatized and novel 
writing task conditions, with group membership (i.e., control versus clinical participants) 
as the independent variable (IV). 
Homogeneity of variance.  Homogeneity of variance was assessed by first 
identifying outlier variables (i.e., data with derived z-scores greater than |2.5|) and next 
using Levene’s test of equality of error variances, with statistical significance of the latter 
(i.e., p < .05) reflecting a potential violation of this assumption.  The following outliers 
were identified: one control participant within the Estimated IQ dependent variable (DV) 
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and one clinical participant within both the NJ DV during automatized graphomotor 
execution while on ADHD medication as well as within the NJ DV during automatized 
graphomotor execution while off ADHD medication.  In turn, all subsequent analyses of 
assumptions were conducted with and without the inclusion of outliers for comparative 
purposes.  A significant Levene’s statistic was found between the variances of the ADHD 
group on medication and control participants within the NJ DV during the automatized 
writing task.  No other statistical significance was found using Levene’s test, indicating 
that the variation within conditions was roughly equivalent for all other comparisons.  
When outliers were removed from the dataset, homogeneity of variance statistics 
improved for the NJ DV during the automatized writing task when comparing control 
participants versus clinical participants on ADHD medication, but statistical significance 
persisted.  Removing the outlier found within the Estimated IQ DV did not affect the 
non-significant finding of Levene’s test of homogeneity of variance, and in fact moved 
the data closer towards heterogeneity of variance.   
It is important to note that ANOVA may be robust to violations of homogeneity 
of variance when comparison groups are equal or nearly equal in size (i.e., the larger 
group contains less than 1.50 times the number of participants than the smaller group) 
and when the variance distribution between the largest and smallest variances is not 
greater than a 4:1 ratio.  The control group was 3.75 times larger than the clinical group 
and 4.29 times larger than the clinical group for comparisons in which outliers were 
removed.  In addition, when outliers were retained, the variance distribution between the 
largest and smallest variance in NJ data during the automatized writing task comparing 
the ADHD group on medication and control participants was over 20:1.  When outlier 
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data was removed, the variance ratio in this comparison decreased substantially to almost 
5:1.  Variance data are presented in Table 2 and the results of homogeneity of variance 
testing are summarized in Table 3. 
Table 2 
Variance of Data Within Conditions 
Dependent 
Variable 
  
Group 
Variance 
(With Outliers) 
Variance 
(Without Outliers) 
Estimated IQ Control 
ADHD 
 
122.01 
201.84 
88.92
†
 
201.84 
Current ADHD Control 
ADHD 
 
63.10 
117.64 
63.10 
117.64 
Childhood ADHD  Control 
ADHD 
 
60.44 
54.12 
60.44 
54.12 
NJ – Auto Control 50.66 50.66 
  On Rx 1028.50 243.96
†
 
  Off Rx 
 
715.81 98.98
†
 
RPV – Auto Control 0.0015 0.0015 
  Off Rx 
 
0.0019 0.0019 
RPV – Novel Control 0.0026 0.0026 
  Off Rx 0.0037 0.0037 
Note.  IQ = Estimated Full Scale IQ; NJ = Normalized Jerk; RPV = Relative 
Intraindividual Peak Velocity.  Rx = Clinical/ADHD participants’ medication status (On 
or Off medication). 
†
 = a change in value from “with outliers” to “without outliers.” 
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Table 3 
Levene’s Test of Homogeneity of Variance 
    
F 
  
df 
  
Sig. 
Dependent 
Variable 
Group 
Comparison 
  
w 
 
w/o 
  
w 
 
w/o 
  
w 
 
w/o 
Estimated IQ Control vs. ADHD  0.58 1.56  1, 36 1, 35  .45 .22 
Current 
ADHD 
Control vs. ADHD  0.14 0.14  1, 36 1, 36  .71 .71 
Childhood 
ADHD 
Control vs. ADHD  0.04 0.04  1, 36 1, 36  .85 .85 
NJ – Auto Control vs. On Rx  22.50 10.02†  1, 36 1, 35  .00* .00* 
NJ – Auto Control vs. Off Rx  12.40 2.75†  1, 36 1, 35  .70 .08 
NJ – Auto On Rx vs. Off Rx  0.30 1.25†  1, 14 1, 12  .59 .29 
RPV – Auto Control vs. Off Rx  0.22 0.22  1, 36 1, 36  .64 .64 
RPV – Novel Control vs. Off Rx  0.17 0.17  1, 36 1, 36  .68 .68 
Note.  Analyses of the assumption of homogeneity of variance within the data.  IQ = 
Estimated Full Scale IQ; NJ = Normalized Jerk, RPV = Relative Intraindividual Peak 
Velocity; Auto = automatized writing condition; Rx = ADHD participants’ medication 
status (On or Off medication); w = results with outliers; w/o = results without outliers.   
* = statistical significance (p < .05) and violation of the assumption of homogeneity of 
variance.  
†
 = a change in value from “with outliers” to “without outliers.” 
 
Normality and Independence of Observations.    The assumption of normality 
was tested by analyzing skewness, kurtosis, and Shapiro-Wilk statistics.  With the 
inclusion of outlier scores, skewness z-scores were outside conventional cut-offs of 
significance (i.e., skewness greater than |2|) for the NJ DV within the control group under 
the automatized condition as well as for the NJ DV within the clinical group off ADHD 
medication, both of which indicated a positive skew and a potential violation of the 
assumption of normality.  All other cells did not reflect significant positive or negative 
skewness.  Kurtosis z-scores, however, were greater than conventional cutoffs (i.e., 
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kurtosis greater than |3|) for the NJ DV under the automatized writing task for controls, 
clinical participants on ADHD medication, and clinical participants off ADHD 
medication, indicating significant leptokurtic kurtosis.  The Shapiro-Wilk statistic was 
also statistically significant for these same cells as well as for the Current Total ADHD 
Score as measured by the BAARS-IV.  Within the RPV DV, no significant skewness or 
kurtosis was observed, and the Shapiro-Wilk statistic was non-significant for all data 
cells for this variable.  This in turn indicated that RPV results represented the only 
normally distributed experimental data.  Removing outlier data resulted in normalizing 
the distribution of data with regard to skewness and kurtosis for all data cells with the 
exception of the NJ DV under the automatized writing task within the control group, 
which retained its significantly positive skew and significantly leptokurtic distribution.  
In addition, the NJ DV under the automatized writing task continued to produce a 
significant Shapiro-Wilk statistic within the clinical participant group on ADHD 
medication.   
ANOVA is said to be robust to violations of normality when sample sizes are 
large and group sizes are roughly equivalent.  Noting the relatively small sample size and 
large group size differences within the sample, the violations of normality found within 
the NJ DV while retaining outlier variables would significantly impact the reliability of 
the ANOVA F statistic for all comparisons involving the NJ DV.  Removing outlier data 
normalized the distribution of NJ results for clinical participants off ADHD medication, 
but not for NJ results for the control group or clinical participants on ADHD medication.   
Tests of normality data, with and without outliers, are summarized in Table 4. 
 
31 
 
31 
Table 4 
Normality of Data 
   Skewness  Kurtosis  Shapiro-Wilk 
Dependent 
Variable 
 
Group 
 
w 
 
w/o 
  
w 
 
w/o 
  
w 
 
w/o 
Estimated IQ Control 
Clinical 
 
0.58 
-0.52 
-0.14
†
 
-0.52 
 1.03 
-0.12 
-0.70
†
 
-0.12 
 .34 
.78 
.32
†
 
.78 
Current Total 
ADHD Score 
Control 
Clinical 
 
1.10 
0.30 
1.10 
0.30 
 1.58 
-1.72 
1.58 
-1.72 
 .03* 
.20 
.03* 
.20 
Childhood Total 
ADHD Score 
Control 
Clinical 
 
0.02 
-0.40 
0.02 
-0.40 
 -1.14 
-1.14 
-1.14 
-1.14 
 .23 
.31 
.23 
.31 
NJ – Auto Control 2.28* 2.28*  7.63* 7.63*  .00* .00* 
  On Rx 1.89 1.40
†
  3.53* 0.73
†
  .01* .03*
†
 
  Off Rx 
 
2.19* 1.11
†
  5.09* 0.44
†
  .00* .17
†
 
RPV - Auto Control 0.02 0.02  0.10 0.10  .31 .31 
  Off Rx 
 
1.38 1.38  1.88 1.88  .15 .15 
RPV - Novel Control 0.42 0.42  -0.89 -0.89  .06 .06 
  Off Rx 
 
0.93 0.93  -0.86 -0.86  .06 .06 
Note.  Analyses of the assumption of normality of distribution within the data.  NJ = 
Normalized Jerk; RPV = Relative Intraindividual Peak Velocity; Auto = Automatized 
writing task; Rx = ADHD participants’ medication status (On or Off medication); w = 
results with outliers; w/o = results without outliers.  * = statistical significance (p < 
.05) and violation of the assumption of normality.  
†
 = a change in value from “with 
outliers” to “without outliers.” 
 
Finally, data were gathered from participants in individual sessions.  Combined 
with the general novelty of the experimental tasks utilized, lack of known organized 
communication between participants, and the manner in which data were gathered, it is 
unlikely that participants’ scores were systematically related. 
Taken together, the non-normally distributed data on the NJ DV for control 
participants and clinical participants on ADHD medication combined with the 
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heterogeneity of variance found comparing these two groups increases the risk of Type 1 
errors when conducting analyses based on NJ data.  In addition, largely unequal sample 
sizes and variance distributions greater than 4:1 make conclusions drawn from NJ DV 
results during the automatized writing task tenuous due the additional violation in the 
assumption of normality.  Again, removing outlier data improved the normality of the 
data, but did not eliminate non-normality entirely.  Given the above stated issues 
associated with the data and the assumptions of ANOVA, 1) all subsequent analyses were 
conducted without the presence of outlier scores on the NJ DV and 2) nonparametric 
statistical analyses were also conducted for comparisons between control and clinical 
participants on ADHD medication that involve using the NJ DV in order to provide 
support for, or against, significant findings that were found using parametric statistics. 
Demographics and ADHD Symptomatology  
Data pertaining to participant demographics, estimated IQ, and presence of 
ADHD symptomatology were collected for the purposes of sample description.  
ANOVAs were performed to determine significant initial group differences when 
appropriate.   
In the overall sample, more participants were right-handed (84.21%) than left-
handed (15.79%), more women (78.95%) participated in the study than men (21.05%), 
and a majority of the participants self-identified as Caucasian (71.05%).  Between the 
control and clinical participant groups, a greater proportion of clinical participants were 
left-handed (37.50%) than control participants (10.00%).  Fortunately, kinematic 
variables have not been shown to be affected by handedness alone (Mergl et al., 1999).  
There was a greater proportion of men in the clinical participant sample (62.50%) than in 
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the control participant sample (10.00%).  A slightly greater representation of non-
dominant ethnic/racial group members was also observed in the clinical participant 
sample (33.33%) versus the control participant sample (20.00%). 
Overall, control participants (M = 27.56, SD = 11.91) were younger than clinical 
(M = 35.00, SD = 9.08) participants, but not significantly, F(1, 36) = 2.69, p = .110, and 
with a small effect size, ω2 = .043.  There was, however, a broader age range in control 
participants (age range: 18.58–54.08 years) versus clinical participants (age range: 23.25–
46.60 years).  Control (M = 94.17, SD = 11.05) and ADHD (M = 94.88, SD = 14.21) 
participants performed nearly identically on the general test of intellectual ability as a 
group, F(1, 36) = 0.02, p = .880, ω2 = .000, with both groups falling within the average 
range.  Please see Table 5 for a summary of all participant demographic information. 
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Table 5 
 
Participant Demographic Information 
 
 Control  ADHD 
 n M SD  n M SD 
Handedness        
Right 27 - -  5 - - 
Left 
 
3 - -  3 - - 
Sex        
Women 27 - -  3 - - 
Men 
 
3 - -  5 - - 
Race/Ethnicity        
Asian 2 - -  0 - - 
Black 3 - -  1 - - 
Caucasian 24 - -  6 - - 
Hispanic 
 
1 - -  1 - - 
Age 
 
- 27.56 11.91  - 35.00 9.08 
Estimated IQ 
 
- 94.17 11.05  - 94.88 14.21 
Note.  Estimated IQ = estimate of general intellectual ability.  ADHD = 
clinical participants diagnosed with ADHD. 
 
Participant ratings of ADHD symptomatology as measured by the BAARS-IV are 
summarized in Table 6.  Clinical participants rated current ADHD symptomatology (M = 
48.88, SD = 7.86) as occurring significantly more frequently than control participants (M 
= 30.00, SD 7.94), F(1, 36) = 35.80, p < .001, with an observed large effect size, ω2 = 
.478.  In addition, clinical participants reported significantly more symptoms of ADHD 
that occurred during childhood (M = 50.88, SD = 7.36) than did control participants (M = 
30.67, SD = 7.77), F(1, 36) = 43.56, p < .001, also with a large effect size, ω2 = .528. 
 
   
35 
 
35 
Table 6 
BAARS-IV ADHD Symptomatology 
  Control  Clinical 
  M SD  M SD 
Current Symptom Total 
ADHD Score: 
 
 30.00 7.94  48.88 7.86 
Childhood Symptom 
Total ADHD Score: 
 
 30.67 7.77  50.88 7.36 
 
As shown in Table 7, a greater proportion of clinical participants also reported 
clinically significant levels of current (100%) and childhood (87.50%) ADHD 
symptomatology compared to control participants (significant levels of current ADHD 
symptomatology = 13.3%, significant levels of childhood ADHD symptomatology = 
0%).  Taken together, it can be reasonably concluded that clinical participants reported 
significantly higher levels of current and childhood ADHD symptoms than control 
participants.  Finally, ADHD subtypes diagnosed in clinical participants included ADHD-
C (n = 5), ADHD-PI (n = 1), and ADHD-HI (n = 2). 
Table 7 
Number of Participants with BAARS-IV Scores ≥ 93rd %tile 
  Control  Clinical 
  n  n 
Current Symptom Total 
ADHD Score: 
 4 (13.30%)  8 (100%) 
Childhood Symptom 
Total ADHD Score: 
 0 (0.00%)  7 (87.50%) 
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Kinematic Analyses 
Overlap with past research.  Due to multiple comparisons and the relatively low 
risk involved with rejecting a true null hypothesis, a Bonferroni correction was used for 
all statistical comparisons.  As such, the alpha level for statistical comparisons made to 
determine support for past research was adjusted to .02.  Two One-Way ANOVAs were 
used to compare the handwriting fluency of controls with clinical participants both on 
ADHD medication as well as off ADHD medication.  Between group comparisons based 
on fluency measures detected no statistically significant differences between control (M = 
18.43, SD = 7.12) and clinical participants taking ADHD medication (M = 25.57, SD = 
15.62), F(1, 35) = 3.45, p = .072, but did demonstrate a medium effect size, ω2 = .062.  
This non-significant finding was consistent with previous research.  Nonparametric 
statistical analysis (i.e., the Mann-Whitney U Test) also indicated that this difference was 
not statistically significant, p = .435, and that the null hypothesis should be retained.  The 
handwriting fluency scores of clinical participants off ADHD medication (M = 21.10, SD 
= 10.47) compared to those of control participants (M = 18.43, SD = 7.12) were not 
significantly different, F(1, 35) = 0.66, p = .421, and demonstrated an uninterpretable 
effect size, ω2 = .000.  Combined, these non-significant findings are consistent with 
previous research. 
A repeated measures One-Way ANOVA was used to examine automatized 
handwriting fluency (i.e., NJ) of clinical participants taking ADHD medication versus 
those same participants discontinuing their ADHD medication for 24 hours.  The results 
comparing the handwriting fluency of clinical participants on ADHD medication (M = 
25.57, SD = 15.62) versus off ADHD medication (M = 21.10, SD = 10.47) did not 
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identify a statistically significant difference, F(1, 6) = 1.51, p = .265.  This result is 
consistent with previous findings in that handwriting fluency of clinical participants did 
not differ significantly based on medication status.  Although not a statistically 
significant difference, a medium effect size was found, ω2partial = .068.  See Table 8 for a 
summary of automatized fluency results as well as source data for statistical comparisons 
and Figure 3 for a graphical comparison of the automatized writing fluency of control 
participants versus clinical participants both on and off ADHD medication. 
Table 8 
Automatized Writing Fluency – Summary and Source Table 
 
 
Source 
  
M 
 
SD 
 
SS 
 
df 
 
MS 
 
F 
 
p 
 
ω2 
Group Membership - - 289.14 1 289.14 3.45 .072 .062 
Error Between - - 2932.99 35 83.80 - - - 
 Control 18.43 7.12 - - - - - - 
 On Rx 
 
25.57 15.62 - - - - - - 
Group Membership - - 40.24 1 40.24 0.66 .421 .000 
Error Between - - 2127.38 35 60.78 - - - 
 Control 18.43 7.12 - - - - - - 
 Off Rx 
 
21.01 10.47 - - - - - - 
Medication Status - - 70.09 1 70.09 1.51 .265 .068
†
 
Error Residual   278.44 6 46.41 - - - 
 On Rx 25.57 15.62 - - - - - - 
 Off Rx 
 
21.10 10.47 - - - - - - 
Note.  On Rx = ADHD/Clinical participants on ADHD medication; Off Rx = 
ADHD/Clinical participants off ADHD medication.  M = mean of normalized jerk (NJ) 
value; SD = standard deviation of normalized jerk (NJ) value.  
†
 = partial omega-squared. 
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Figure 3.  Automatized writing fluency of control and clinical participants.  NJ = 
Normalized Jerk.  Higher values of NJ indicate more dysfluent writing, whereas lower 
values of NJ indicate more fluent and automatized writing.  ADHD On Rx = 
ADHD/Clinical participants on ADHD medication; ADHD Off Rx = ADHD/Clinical 
participants off ADHD medication. 
 
Variability of graphomotor performance.  The alpha level was set at .05 to 
indicate statistical significance for the following comparisons.  A One-Way ANOVA was 
used to analyze the kinematic variability of automatized handwriting performance (i.e., 
RPV) of healthy control participants with that of ADHD participants that discontinued 
ADHD medication for 24 hours.  No main effect was found related to group membership 
and variability of graphomotor performance, F(1, 36) = 0.37, p = .545, and no 
interpretable effect size was found, ω2 = .000, indicating that clinical participants not 
taking ADHD medication (M = 0.12, SD = 0.06) demonstrated similar variability in 
automatized graphomotor performance to control participants (M = 0.13, SD = 0.04).  See 
Table 9 for a summary of graphomotor variability findings as well as source information.  
See Figure 4 for a graphical comparison of graphomotor variability findings. 
Control ADHD On Rx ADHD Off Rx 
NJ 18.43 25.57 21.10 
0.00 
5.00 
10.00 
15.00 
20.00 
25.00 
30.00 
Automatized Writing Fluency 
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Table 9 
 
Automatized Writing Variability – Summary and Source Table 
 
 
Source 
 
M 
 
SD 
 
SS 
 
df 
 
MS 
 
F 
 
p 
 
ω2 
Group Membership - - .001 1 .001 0.37 .545 .000 
Error Between - - .057 36 .002 - - - 
Control .13 .04 - - - - - - 
Off Rx 
 
.12 .04 - - - - - - 
Note.  Off Rx = ADHD/Clinical participants off ADHD medication.  M = mean of the 
relative intraindividual mean peak velocity (RPV) value; SD = standard deviation of the 
relative intraindividual mean peak velocity (RPV) value. 
 
 
Figure 4.  Variability of handwriting performance in control and clinical participants.  
RPV = Relative Intraindividual Mean Peak Velocity.  Less consistently controlled 
movements are indicated by higher values and more consistently controlled movements 
reflected by lower values.  ADHD Off Rx = ADHD/Clinical participants off ADHD 
medication. 
 
The effects of novelty on variability.  A 2 x 2 factorial mixed design ANOVA 
was used to compare the effects of novelty on variability measures in those diagnosed 
with ADHD off medication versus healthy controls.  There was a significant main effect 
Control ADHD Off Rx 
RPV 0.13 0.12 
0.00 
0.05 
0.10 
0.15 
0.20 
0.25 
0.30 
Automatized Writing Variability 
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for writing task, F(1, 36) = 24.86, p < .001, indicating that overall, more variable and less 
consistent handwriting was seen in participants when performing the novel writing task 
(M = 0.18, SD 0.06) versus the automatized writing task (M = 0.12, SD = 0.04).  The 
effect size for the writing task main effect was large, ω2partial = .333.  However, no 
significant interaction effect was observed, F(1, 36) = 0.11, p = .740, with no 
interpretable effect size, ω2partial = .000.  See Table 10 for source information pertaining to 
graphomotor variability findings as a function of writing task.  See Figure 5 for a 
graphical comparison of graphomotor variability findings related to writing task. 
Table 10 
 
Graphomotor Variability as a Function of Novelty –Source Table 
 
 
Source 
 
SS 
 
df 
 
MS 
 
F 
 
p 
 
ω2 
Within Subjects       
Writing Task 0.040003 1 0.040003 24.86 <.001* .333 
Error Within 
 
0.057937 32 0.001609 - - - 
Interaction       
Writing Task x Group 
Membership 
0.000180 1 0.000180 0.11 .740 .000 
Error Interaction 
 
0.057937 32 0.001636 - - - 
Note.  * = statistical significance p < .05 
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Figure 5.  Handwriting variability based on writing task.  RPV = Relative Intraindividual 
Mean Peak Velocity.  Less consistently controlled movements are indicated by higher 
values and more consistently controlled movements reflected by lower values.  ADHD 
Off Rx = ADHD/Clinical participants off ADHD medication. 
 
Automatized RPV Novel RPV 
Control 0.13 0.18 
ADHD Off Rx 0.12 0.17 
0.10 
0.11 
0.12 
0.13 
0.14 
0.15 
0.16 
0.17 
0.18 
0.19 
Graphomotor Variability as a Function of Novelty 
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CHAPTER V 
CONCLUSIONS AND RECOMMENDATIONS 
Discussion 
Utilizing a digitizing tablet and specialized kinematic analyses software to 
quantify  graphomotor performance during putatively automatized and novel writing 
tasks in adults with and without a diagnosis of ADHD, the present study sought to: 1) 
determine whether the variability of performance observed in other psychological 
domains in those diagnosed with ADHD would manifest within kinematic variables 
associated with stability and coordination of graphomotor output (i.e., RPV) and 2) 
determine whether a novel writing task would differentially affect the variability of 
graphomotor output of adults diagnosed with ADHD compared to healthy controls. 
Overlap with past research.  Consistent with prior research (Tucha & Lange, 
2004), results of the present study suggest that automatized graphomotor fluency, as 
measured by kinematic analysis, is not significantly different in adults diagnosed with 
ADHD taking prescribed dosages of stimulant medication from that of neurotypical 
adults.  This conclusion was supported using both parametric and nonparametric 
statistical analysis.  Despite these non-statistically significant findings that appear to 
corroborate past research, this conclusion should be accepted cautiously.  Findings of 
statistical significance using ANOVA or other analyses under the general linear model 
are affected by sample size.  That is, as sample size increases, the likelihood of finding a 
statistically significant result continues to increase, even when differences in performance 
are relatively small.  As such, the power of the research design, which takes into account 
sample size, effect size, and alpha level, must also be considered.  Noting the medium 
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effect size (ω2 = .062) and the relatively small number of clinical participants (n = 7) 
within this study, it is likely that this non-statistically significant finding is due to low 
power rather than non-significant differences between healthy adults and adults 
diagnosed with ADHD on stimulant medication.  In turn, a statistically significant result 
may have been found if the clinical sample was larger and fluency results within the 
study maintained the same pattern. 
Also consistent with previous research, adults diagnosed with ADHD off 
medication produced similarly fluent automatized graphomotor output as control 
participants without ADHD.  Although an argument could be made that increased power 
via a larger sample of clinical participants may result in the formulation of a different 
conclusion, the extremely small (and uninterpretable) effect size observed in this study 
combined with both the adherence to the assumptions of ANOVA and findings that are 
consistent with previous research strongly suggest that this conclusion is reliable and 
valid. 
Concerning the handwriting fluency of adults diagnosed with ADHD on stimulant 
medication versus those same adults off ADHD medication, the present study was 
consistent with previous research indicating no statistically significant difference in 
automatized graphomotor fluency.  This finding suggests that medication status may not 
affect the graphomotor fluency of adults diagnosed with ADHD when performing an 
automatized writing task.  Again, this interpretation must be made with caution.  Similar 
to the above results comparing the automatized graphomotor fluency of control 
participants with that of clinical participants on ADHD medication,  the medium effect 
size (ω2 = .068) found in the comparison of adults with ADHD on medication versus off 
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medication suggests that non-significant findings could be the result of insufficient 
statistical power associated with a small clinical participant sample. 
However, if statistical power were sufficient and statistically significant findings 
related to differences in automatized graphomotor fluency were found between adults 
with ADHD on stimulant medication versus off ADHD medication, as well as between 
adults with ADHD on stimulant medication versus control participants, results would still 
need to be interpreted cautiously due to other methodological considerations.  First, 
graphomotor fluency in previous research was operationalized as the mean number of 
inversions in the direction of vertical velocity over time (Tucha & Lange, 2004).  In this 
study, however, graphomotor fluency was operationalized as normalized jerk, which is 
derived from the number of changes in acceleration in time (analogous to the number of 
changes in velocity over time) but was then normalized due to the effects of size and 
duration of movements on fluency measures (Tuelings et al., 1997).  Using the NJ 
variable as opposed to the mean number of inversions in velocity provided the benefit of 
validly comparing graphomotor fluency of the word “hello” and the symbol “ .”  
However, the NJ variable may not be completely analogous to previously used measures 
quantifying automatized graphomotor fluency in adults with ADHD.  As such, the 
derived fluency measures of this study may not be completely comparable with those of 
past research investigating graphomotor fluency in adults with ADHD.   
Secondly, the previous study investigating graphomotor fluency in adults 
diagnosed with ADHD analyzed the specific letter combination of “ll” within two 
German words (Tucha & Lange, 2004).  The present study, however, analyzed the entire 
word “hello” to determine automatized graphomotor fluency.  Intuitively, the 
45 
 
45 
biomechanical forces necessary to generate the letters “ll” versus the word “hello” are 
different based upon salient graphemic differences.  In turn, conclusions drawn from 
comparisons between the current study and past research should be done with caution 
noting that differences in graphomotor fluency findings may be due, at least in part, to the 
experimental stimulus used. 
Variability of graphomotor performance.  Using the kinematic variable RPV, 
clinical participants exhibited variability in graphomotor output when executing an 
automatized writing task that was similar to that of control participants.  As such, the 
results of this study suggest that the variability of performance observed in various 
psychological domains (e.g., emotional expression, handwriting production, fine motor 
skill movements, motor coordination, and motor force output) within the ADHD 
population may not be manifest within the kinematic measures of stability, consistency, 
and coordination used in this study, in which participants performed an automatized 
graphomotor task.   
This was the first such research to utilize RPV as a measure of variability of 
graphomotor performance in adults diagnosed with ADHD.  Previous research utilizing 
the RPV measure to study kinematic aspects of handwriting  in clinical populations 
focused on patients diagnosed with probable Alzheimer’s dementia (AD) (Schroter et al., 
2003).  In this research, Schroter and colleagues found that when performing a spiral 
drawing task, participants with probable AD exhibited significantly more variability, 
incoordination, and greater inconsistency in the kinematics of handwriting movements 
compared to similarly aged healthy control participants.  One of the primary rationales 
for conducting this study was the high co-occurrence of salient motor dysfunction found 
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within the AD population: a high prevalence of Parkinsonism and various extrapyramidal 
motor symptoms.  Although motor problems have also been documented in those with 
ADHD, motor sequelae in the ADHD population may be more subtle than what is 
observed in patients with AD.  Accordingly, a failure to demonstrate significant 
differences in consistency of graphomotor output between adults with ADHD and healthy 
controls could be the result of less than optimal sensitivity of the RPV measure in 
detecting subtle motor differences in the ADHD population.   
Further, how the RPV measure was derived may have created an insensitive 
measure that failed to detect intraindividual variability of graphomotor production.  That 
is, the mean peak velocity was collapsed across all strokes within each trial and then 
averaged with all 30 trials of each writing task.  The RPV, which is a coefficient of 
variation (CV), was then determined for each participant by dividing the standard 
deviation of the mean peak velocities by the average of the mean peak velocities across 
all trials.  As such, this collapsed mean may not have optimally reflected variability of 
graphomotor performance with sufficient sensitivity because variability within each 
individual writing trial was not taken into consideration when calculating the RPV.  Said 
another way, deriving the RPV variable to indicate intraindividual variability by creating 
a CV based on the averages and standard deviation of mean peak velocities across all 
trials rather than deriving the RPV variable based upon an average of the coefficients of 
variation of mean peak velocities calculated within each trial may have underestimated 
the intraindividual variability of automatized and novel graphomotor output. 
The writing tasks themselves may also not have optimally allowed participants to 
demonstrate significant variability of graphomotor performance.  For example, previous 
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work utilizing the RPV variable has demonstrated no statistically significant differences 
in intraindividual variability of handwriting between men and women when writing 
letters or simple geometric figures (Mergl et al., 1999).  However, in this same study, 
statistically significant gender differences in intraindividual variability of graphomotor 
performance emerged when participants executed a six word sentence. 
Bearing in mind the methodological and statistical considerations mentioned 
above, the findings of the present study suggest the following: 1a) conclusions 
concerning the fluency of automatized graphomotor performance in healthy controls as 
compared with adults diagnosed with ADHD taking stimulant medication can only be 
tentatively drawn at this time.  These findings, in combination with past findings, suggest 
that the automatized graphomotor fluency between these groups is similar.  However, 
medium effect sizes suggest that real differences may be present and would be detected if 
statistical power were greater.  1b) A negligible observed effect size, non-significant 
findings, and replication of past research provide strong evidence that the graphomotor 
fluency of adults with ADHD off stimulant medication is similar to the fluency of 
individuals without ADHD.  2) Conclusions regarding the fluency of automatized 
graphomotor performance in adults with ADHD on stimulant medication versus off 
ADHD medication can only be tentatively drawn.  The medium effect size found within 
this comparison suggests potential differences in automatized graphomotor fluency in 
adults with ADHD on stimulant medication versus off medication.  3) Variability of 
performance, as measured by the RPV variable, does not appear to manifest within the 
graphomotor domain in adults diagnosed with ADHD.  However, more sensitive 
measures of intraindividual variability of graphomotor performance or different writing 
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tasks may yield different results and in turn, support an alternative conclusion.  4) The 
novelty of a graphomotor task does not appear to differentially affect the variability of 
kinematic handwriting performance in adults diagnosed with ADHD as measured by the 
RPV variable.  As mentioned previously concerning the RPV variable, however, different 
results may be found by calculating a more sensitive measure of intraindividual 
variability of graphomotor performance. 
An additional aim of this study was to add to the current literature demonstrating 
that ADHD is not simply a disorder of childhood, but rather, a condition that involves 
specific motor differences that persist into adulthood.  Although differences in motor 
functioning as measured by the kinematic analyses utilized in this study were not 
statistically significant, effect size differences and methodological considerations do not 
support the conclusion that motor symptoms do not persist into adulthood.  Rather, the 
results of this study support implementing improved methodology and statistical analyses 
to further explore potential motor skill differences in those with ADHD that may persist 
into adulthood.   
Further, this study aimed to find support for the use of digitizing technology as an 
objective diagnostic and descriptive tool within the ADHD population, which would in 
turn enhance the specificity and/or sensitivity of current assessment and diagnostic 
techniques.  Although significant differences in graphomotor function were not observed 
between adults with ADHD and healthy controls utilizing the proposed kinematic 
analyses, when considering the methodological and statistical concerns associated with 
this study, it is likely too early to conclude that kinematic analysis utilizing digitizing 
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technology would not create an added benefit when attempting to describe graphomotor 
performance differences in the adult ADHD population versus unaffected adults. 
Methodological Limitations.  This project began with several pragmatic 
considerations, including researching and obtaining appropriate hardware and software, 
developing research protocols, and learning how to interpret the results of kinematic 
analyses based on digitizing technology.  As such, the present study served as a 
foundation for future kinematic research utilizing digitizing technology in an effort to 
understand fine motor and graphomotor skill performance of adults and children with 
ADHD.  An additional benefit of this study was to implement a novel protocol and 
evaluate the feasibility of future research questions.  Although this was not a direct goal, 
the results and implementation of this project did have the benefit of establishing the 
limitations of kinematic research utilizing digitizing technology.  Nevertheless, 
methodological limitations and limitations of statistical analyses used may have affected 
the results, and in turn the conclusions of this study. 
Beyond the concerns mentioned above, the primary limitation of this study was 
the small number of clinical participants that were recruited and as such, low statistical 
power.  Post-hoc power analyses using G*Power software (Buchner, Erdfelder, Faul, & 
Lang, 2009) confirmed the low power of this study, which ranged from 1-β = .19 to 1-β = 
.74 for all statistical analyses.  In addition, when sample sizes are small, data are unstable 
and yield statistics that are unreliable.  An additional problem that this small clinical 
sample size created was a situation in which the two comparison groups were largely 
unequal in size.  This additional problem further decreases the reliability of the F statistic 
and its ability to help draw conclusions.  In the future, recruitment strategies should 
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involve broadening the pool from which clinical participants are drawn by increasing the 
number of sources from which participants are recruited.  However, the present study 
could also be considered an initial work in progress, with additional recruitment of 
participants scheduled to occur in the future. 
In addition, parametric statistical analyses in this study utilized the general linear 
model.  These statistical analyses used to determine both group differences in the 
variability of automatized graphomotor performance and the effect of novelty on these 
measures of variability may not have been sufficiently sensitive in detecting 
intraindividual differences.  For example, King, Harring, Oliveira, and Clark (in press) 
utilized both a general linear model statistic (i.e., ANOVA) as well as a random 
coefficient model technique to study intra- and inter-individual variability of motor 
movements in healthy children and children diagnosed with DCD.  In summary, King 
and colleagues found that the random coefficient model identified intra- and inter-
individual differences in task execution that the general linear model analysis did not 
detect.  As such, the use of ANOVA to analyze intraindividual differences in automatized 
graphomotor performance may not have been the most appropriate or sensitive statistical 
model for the purposes of this research question. 
Future Research 
The results and methodology used in this study suggest multiple lines of research 
that should be explored in the future.  First, the present study sought to understand the 
variability of graphomotor performance using a CV derived from the average of mean 
peak velocities for each word or symbol across 30 trials.  Alternatively, variability could 
be expressed as a CV of average fluency results in both automatized and novel writing 
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tasks.  That is, variability of graphomotor performance in adults with ADHD could be 
explored using a derivative of the NJ variable rather than a derivative of mean peak 
velocity.  In addition, and as mentioned above, future research should attempt to 
understand variability of graphomotor performance by utilizing an alternative calculation 
of the intraindividual variation of graphomotor functioning.  This would involve 
computing the average of the CVs of mean peak velocity per trial rather than the CV of 
the average mean peak velocity collapsed across all trials.  Finally, future research into 
intraindividual variability of performance could benefit from using more powerful and 
elegant statistical analyses.  As demonstrated by King et al. (in press), the use of 
statistical techniques based upon a random coefficient model may have greater power to 
detect intraindividual differences in motor skill performance than do techniques based 
upon the general linear model. 
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APPENDICES 
APPENDIX A 
Interview Questionnaire 
 
Name: _____________________________________      
 
In what month and year were you born? _________________________ 
 
How would you describe your Sex or Gender?  _____________________ 
 
What hand do you primarily use to write with? Right Hand Left Hand
 Ambidextrous 
 
What medications are you currently taking?  Please include dosage information. 
 
Medication Dosage Medication Dosage 
    
    
    
    
    
    
    
    
    
    
  
Some people use terms such as Arabic, Asian, Black, Hispanic, White, or similar 
terms to describe their ethnicity.  What term would you use to describe your 
ethnicity? ______________ 
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Do you currently have a diagnosis of ADHD?  If yes, what is that official diagnosis? 
________________________________________________________________________ 
Do you have a current diagnosis or diagnoses affecting the central nervous system 
or peripheral nervous system that would impair your ability to take part in a 
writing task?  An example of central nervous system diagnosis affecting writing 
ability includes cerebral palsy affecting the arms and/or hands, and an example of 
peripheral nervous system diagnosis affecting writing ability includes carpal tunnel. 
________________________________________________________________________ 
________________________________________________________________________ 
 
Is there any other information that you feel may affect your participation in this 
study that you would like me to know? 
________________________________________________________________________ 
________________________________________________________________________ 
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APPENDIX B 
 
Figure B1.  Scaled version of novel symbol. 
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